UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017076
Receipt number R000019808
Scientific Title The usefulness and Safety of propofol for benzodiazepine resistance cases in endoscopic sedation
Date of disclosure of the study information 2015/04/08
Last modified on 2019/05/10 09:42:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The usefulness and Safety of propofol for benzodiazepine resistance cases in endoscopic sedation

Acronym

Propofol for benzodiazepine resistance cases in endoscopic sedation

Scientific Title

The usefulness and Safety of propofol for benzodiazepine resistance cases in endoscopic sedation

Scientific Title:Acronym

Propofol for benzodiazepine resistance cases in endoscopic sedation

Region

Japan


Condition

Condition

Disease that requires endoscopic procedures

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In performing an endoscopic procedure, to evaluate the usefulness and safety of propofol for the patient of benzodiazepine derivatives resistance in case of sedation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse events and safety in using propofol

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

We use propofol, if midazolam is insufficient in sedation.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Endoscopy procedures that required sedation.
2.More than 20 years of age.
3.ECOG Performance Status is 0 or 1.
4.There is no severe liver or kidney dysfunction.
5.No contraindication for propofol.
6.Have been obtained the consent of the study participants in the document.

Key exclusion criteria

1. Hypersensitivity history to propofol or formulation.
2. During pregnancy, during lactation.
3. ECOG-Performance Status is over 2 or more.
4. Advanced liver of kidney dysfunction.
5. Determined to be inappropriate to carry out the study.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Shuichi
Middle name
Last name Kaneko

Organization

Kanazawa University Hospital

Division name

Department of Gastroenterology

Zip code

9208641

Address

Takaramachi 13-1, Kanazawa, Ishikawa, JAPAN

TEL

076-265-2235

Email

skaneko@m-kanazawa.jp


Public contact

Name of contact person

1st name Tomoyuki
Middle name
Last name Hayashi

Organization

Kanazawa University Hospital

Division name

Department of Gastroenterology

Zip code

9208641

Address

Takaramachi 13-1, Kanazawa, Ishikawa, JAPAN

TEL

076-265-2235

Homepage URL


Email

hayasix0917@gmail.com


Sponsor or person

Institute

Kanazawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

kanazawadaigaku

Address

takaramachi

Tel

0762652000

Email

doctorugbyknzwtym@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 08 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Publication of results

Unpublished


Result

URL related to results and publications

No

Number of participants that the trial has enrolled

10

Results

No

Results date posted

2019 Year 05 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

No

Participant flow

No

Adverse events

No

Outcome measures

No

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 04 Month 08 Day

Date of IRB

2015 Year 04 Month 08 Day

Anticipated trial start date

2015 Year 04 Month 08 Day

Last follow-up date

2017 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Transfer to JRCT


Management information

Registered date

2015 Year 04 Month 08 Day

Last modified on

2019 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name